Related Experiment Video
Updated: Oct 22, 2025
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
MCUR1 is a prognostic biomarker for ovarian cancer patients
Liming Fan1,1, Hualiang Yang2,1, Bo Zhang3
1Department of Clinical Laboratory, Tianjin Medical University General Hospital, Tianjin, China.
Purpose:
To propose MCUR1 gene as a potential biomarker for ovarian cancer prognosis.
Methods:
The ovarian cancer patient specimen from TCGA database were analyzed using survival analysis. The immune cell infiltration ratio and checkpoints had also been investigated for different expression group of MCUR1. The function of MCUR1 as a ovarian cancer prognosis biomarker was verified in clinic.
Results:
The low expression of MCUR1 was associated with the poor prognosis of ovarian cancer patients. The expressions of majority of immune cells and 6 checkpoints in low expression group of MCUR1 were significantly lower than that in high expression group of MCUR1 (P< 0.05). The MCUR1 could be utilized as a prognostic biomarker for ovarian cancer patients in clinic.
Conclusion:
This study has proposed a potential prognostic biomarker for ovarian cancer patients, which offers a beneficial reference for future ovarian cancer administration.
